High-Intensity Laser Therapy in Patients With Sacroiliitis
Sacroiliac Arthritis
About this trial
This is an interventional treatment trial for Sacroiliac Arthritis
Eligibility Criteria
Inclusion Criteria: Age: Adults aged 40-60 years old Diagnosis: Confirmed diagnosis of sacroiliitis by a specialist (e.g., rheumatologist, orthopedic surgeon, or radiologist) based on a combination of clinical findings, laboratory tests, and imaging studies Clinical findings: Presence of at least one or more of the following clinical signs and symptoms suggestive of sacroiliitis: Low back pain, buttock pain, or hip pain, worsened by prolonged sitting, standing, or walking Stiffness in the lower back, buttock, or hip region, particularly in the morning or following prolonged inactivity Pain improvement with physical activity or exercise Duration of symptoms: Experiencing symptoms for at least 3 months Exclusion Criteria: Previous surgery or invasive procedures targeting the sacroiliac joints Contraindications to physical interventions (e.g., spinal instability, fractures, or severe neurological deficits) Presence of other spinal pathologies or systemic inflammatory conditions that could confound the assessment of sacroiliitis (e.g., lumbar disc herniation, ankylosing spondylitis, or rheumatoid arthritis) Pregnant or breastfeeding women
Sites / Locations
- Outpatient clinic of faculty of physical therapy, Ahram Canadian UniversityRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Sham Comparator
High-Intensity Laser Therapy (HILT) Group
Sham-Control Group
Participants in the HILT group will receive an 8-week course of High-Intensity Laser Therapy (HILT) for the treatment of sacroiliitis. HILT will be administered using a Class IV laser with a wavelength of 980 nm, power output of 10 W, spot size of 0.5 cm, and a dose of 60 J/cm2 per session. The laser will be applied to the affected area of the sacroiliac joint, with the aim of achieving a sensation of warmth in the region. The treatment sessions will be delivered for 10 minutes per session, with a total of 12 sessions over 8 weeks. Participants will receive no other specific interventions during the study period.
Participants in the sham-control group will receive a sham HILT treatment for the treatment of sacroiliitis. The sham treatment will be delivered using a device that looks like the HILT device, but does not emit laser energy. The device will be applied to the affected area of the sacroiliac joint, with the aim of achieving a sensation of warmth in the region. The treatment sessions will be delivered for 10 minutes per session, with a total of 12 sessions over 8 weeks. Participants will receive no other specific interventions during the study period.